RXKINETIX AND INDIAN IMMUNOLOGICALS COLLABORATE ON DEVELOPMENT OF THERMOSTABLE HEPATITIS B VACCINES

RxKinetix Inc., a specialty pharmaceutical company developing new therapeutics focused on un-met needs in oncology care, and Indian Immunologicals Ltd, a leading manufacturer of veterinary and human vaccines, today announced they will collaborate in the development of thermostable Hepatitis B vaccines with improved stability at non-refrigerated temperatures. This project is funded by a grant awarded to RxKinetix from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative.
PR Newswire